Go to JAX® Mice Query Form

Strain Name:

B6.FVB-Tg(IGFBP2)1Miel/J

Stock Number:

008222

Availability:

Under Development for Distribution Colony

To register your interest in this strain go to the Strain Interest Form.
View Pricing for USA, Canada and Mexico
View Pricing for International

General Terms and Conditions

Genes & Alleles   IGFBP2;   Tg(IGFBP2)1Miel;

Product Information

Strain Details

Type JAX® GEMM® Strain - Congenic
Additional information on JAX® GEMM® Strains.
Type JAX® GEMM® Strain - Mutant Strain
Type JAX® GEMM® Strain - Transgenic
Specieslaboratory mouse
Donating Investigator Ajay Shah,   King's College London

Strain Description
Mice hemizygous for the IGFBP-2 transgene are viable and fertile with no reported gross morphological or developmental changes. Transgenic mice overexpress human IGFBP-2 (hIGFBP-2), with hIGFBP-2 mRNA detected in a variety of organs and tissues, including adipose tissue. Overexpression of hIGFBP-2 is associated with reduced susceptibility to obesity and improved insulin sensitivity; transgenic mice are protected from glucose intolerance and increased blood pressure with age, and are also resistant to obesity and insulin resistance on a high fat diet. The phenotype of hIGFBP-2 overexpressing mice may vary between male and female mice. These IGFBP-2 transgenic mice may be useful in studying metabolic homeostasis, adipocyte biology, and the role of insulin-like growth factor binding protein in protecting against obesity- and age-associated complications (such as hypertension and diabetes).

In an attempt to offer alleles on well-characterized or multiple genetic backgrounds, alleles are frequently moved to a genetic background different from that on which an allele was first characterized. As these mice were originally characterized on the FVB/N genetic background, it should be noted that the phenotype could vary from that originally described. We will modify the strain description if necessary as published results become available.

Strain Development
The IGFBP-2 transgene (isolated from a human cosmid clone) contains the entire structural human IGFBP2 gene. This 39 kb transgene was microinjected into the pronucleus of FVB/N embryos. Founder mice (line tg1) were bred to FVB/N mice. After this, IGFBP-2 transgenic mice were backcrossed to C57BL/6J mice for at least 9 generations prior to arrival at The Jackson Laboratory. Upon arrival, mice were additionally backcrossed to C57BL/6J for at least one generation.

Mammalian Phenotype Terms assigned by genotype

The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.

Tg(IGFBP2)1Miel/0

        FVB/N-Tg(IGFBP2)1Miel
  • growth/size phenotype
  • resistance to diet-induced obesity (MGI Ref ID J:121961)
    • on high-fat diet for 32 weeks, mutants remain lean with no significant increase in size of fat depots, whereas wild-type mice have markedly increased size of fat depots when examined at 40 weeks
  • weight gain (MGI Ref ID J:121961)
    • on a high-fat/high-calorie diet for 32 weeks from 8 weeks of age, mutants show attenuated weight gain relative to wild-type mice
  • adipose tissue phenotype
  • abnormal abdominal fat pad morphology (MGI Ref ID J:121961)
    • transgenic mice on high-fat diet for 32 weeks have significant reduction intraabdominal fat than wild-type mice; similarly, regular chow-fed mutants have less abdominal fat than diet-matched controls
  • abnormal adipocyte morphology (MGI Ref ID J:121961)
    • adipocytes are smaller than in wild-type mice, on both regular (1390 vs. 2100 um2 mean cell area) and high-fat chow diets (2800 vs. 5900 um2 mean cell area)
  • decreased adipose tissue amount (MGI Ref ID J:121961)
    • on high-fat diet for 32 weeks, mutants have smaller fat depots than wild-type mice on the same diet when examined at 40 weeks
  • cardiovascular system phenotype
  • *normal* cardiovascular system phenotype (MGI Ref ID J:121961)
    • mutants are protected from age-related hypertension observed in aged wild-type mice
    • decreased systolic blood pressure (MGI Ref ID J:121961)
      • wild-type mice at 40 weeks show increased systolic blood pressure compared to transgenic mice on both regular chow and high-fat diets
  • liver/biliary system phenotype
  • *normal* liver/biliary system phenotype (MGI Ref ID J:121961)
    • on high-fat diet for 32 weeks, mutants exhibit lower liver weight relative to controls when examined at 40 weeks
    • on high-fat diet for 32 weeks, mutants do not exhibit steatosis, whereas wild-type livers have macroscopic appearance compatible with increased fat content
  • homeostasis/metabolism phenotype
  • *normal* homeostasis/metabolism phenotype (MGI Ref ID J:121961)
    • at 8 weeks of age, blood glucose and insulin levels are similar to wild-type mice
    • insulin levels are similar to wild-type at 4-6 months of age
    • on high-fat diet, total energy intake is not significantly different from wild-type
    • abnormal glucose homeostasis (MGI Ref ID J:121961)
      • in response to IGF-I, transgenic mice show an attenuated hypoglycemic response; plasma glucose levels decrease by ~half the value exhibited by wild-type mice
      • abnormal circulating insulin level (MGI Ref ID J:121961)
        • in response to carbohydrate challenge, no siginificant increase in plasma insulin level is observed compared to elevated levels displayed by wild-type mice
      • decreased circulating glucose level (MGI Ref ID J:121961)
        • by 4-6 months of age, transgenic mice display lower nonfasted glucose levels than wild-type littermates
        • increase in blood glucose of transgenic mice on high-fat diet is significantly blunted relative to wild-type
      • improved glucose tolerance (MGI Ref ID J:121961)
        • mice are protected against the age-related decline in glucose tolerance displayed by wild-type mice between 8 and 40 weeks
        • on high-fat diet, transgenic mice are protected from development of glucose intolerance compared to wild-type
        • on both regular and high-fat diets, blood glucose of transgenic mice is significantly lower after glucose tolerance test than in wild-type
      • increased insulin sensitivity (MGI Ref ID J:121961)
        • hypoglycemic response to exogenous insulin is greater in 40-week old mice compared to controls
    • decreased circulating leptin level (MGI Ref ID J:121961)
      • leptin level increase is blunted in transgenic mice on high-fat diet, compared to wild-type
    • decreased circulating triglyceride level (MGI Ref ID J:121961)
      • on high-fat diet, plasma triglyceride levels are significantly lower than in wild-type
    • resistance to diet-induced obesity (MGI Ref ID J:121961)
      • on high-fat diet for 32 weeks, mutants remain lean with no significant increase in size of fat depots, whereas wild-type mice have markedly increased size of fat depots when examined at 40 weeks

Gene & Allele Details

Allele Symbol Tg(IGFBP2)1Miel
Allele Name transgene insertion 1, John Miell
Common Name(s) line tg1;
Mutation Made By John Miell,   University Hospital Lewisham
Strain of OriginFVB/N
Expressed Gene IGFBP2, insulin-like growth factor binding protein 2, 36kDa, human
Promoter IGFBP2, insulin-like growth factor binding protein 2, 36kDa, human
Molecular Note The IGFBP-2 transgene (isolated from a human cosmid clone) contains the entire structural human IGFBP2 gene. This 39 kb transgene was microinjected into the pronucleus of FVB/N embryos. Two lines tg1 and tg2 were established and line tg1 was analyzed in detail. [MGI Ref ID J:121961]

Control Information

  Control
   Noncarrier
   000664 C57BL/6J
 
  Considerations for Choosing Controls

Genotyping Protocols

Tg(IGFBP2)1Miel

Colony Maintenance

Breeding & HusbandryWhen maintaining a live colony, carrier mice may be bred to wildtype or C57BL/6J inbred mice.

Additional Web Information

Congenic Nomenclature

Research Applications

This mouse can be used to support research in many areas including:

Cardiovascular Research
Other

Diabetes and Obesity Research
Insulin Receptors and Growth Factors
Obesity With Diabetes
Obesity Without Diabetes
Type 2 Diabetes (NIDDM)

Metabolism Research

Research Tools
Cardiovascular Research
Diabetes and Obesity Research
Metabolism Research

References

Selected Reference(s)

Wheatcroft SB; Kearney MT; Shah AM; Ezzat VA; Miell JR; Modo M; Williams SC; Cawthorn WP; Medina-Gomez G; Vidal-Puig A; Sethi JK; Crossey PA. 2007. IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes 56(2):285-94. [PubMed: 17259371]  [MGI Ref ID J:121961]

Price and Supply Information

Strain Name: B6.FVB-Tg(IGFBP2)1Miel/J
Stock Number: 008222
 

This strain is currently Under Development for Distribution Colony.
To register your interest in this strain go to the Strain Interest Form.

Estimated Available for Sale Date:

Please note: Estimated available for sale dates are provided to keep customers better informed on strains under development. Please note that our Colony Managers routinely monitor the target date and edit it based on breeding performance and other factors. The length of time it takes to make a new strain available for sale depends on genotype, age, number of animals sent by the Donating Investigator, breeding performance, additional strain development (backcrossing, making homozygous), and anticipated demand for the strain/interest registered.

View All Strains Under Development

Supply Details

Standard SupplyUnder Development for Distribution Colony
Supply Notes This strain is included in the Induced Mutant Resource Colony collection.
LicensingSee General Terms and Conditions below  
Control InformationView Control Information in Strain Details.

General Terms and Conditions

View JAX® Mice & Services Conditions of Use.

The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.
Ordering and Purchasing Information

      Purchasing Information
      JAX® Mice Orders
      Surgical Services

Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form

Go to JAX® Mice Query Form

(2.15)